Peritumoral Microenvironment in High-Grade Gliomas: From FLAIRectomy to Microglia-Glioma Cross-Talk

Roberto Altieri1,2, Davide Barbagallo2,3, Francesco Certo1,2

  • 1Department of Neurological Surgery, Policlinico "G. Rodolico-S. Marco" University Hospital, 95121 Catania, Italy.

Brain Sciences
|February 10, 2021
PubMed

Insights

Microglia in high-grade gliomas (HGGs) have a dual role, either fighting or promoting tumor growth. Targeting microglia-glioma interactions offers new therapeutic strategies for HGGs.

Area of Science:

  • Neuro-oncology
  • Immunology
  • Cancer Biology

Background:

  • The peritumoral area in high-grade gliomas (HGGs) exhibits distinct cellular and molecular characteristics compared to the tumor core.
  • Microglia, immune cells of the central nervous system, are notably abundant at the tumor margins in HGGs.

Purpose of the Study:

  • To review the literature on the role of the peritumoral area in HGGs from both surgical and biological perspectives.
  • To elucidate the dual function of microglia in HGG progression and their interaction with glioma cells.

Main Methods:

  • Literature review focusing on the surgical and biological aspects of the peritumoral microenvironment in HGGs.
  • Analysis of studies investigating microglia polarization (M1 vs. M2 phenotypes) and its implications in HGGs.
  • Examination of the role of extracellular vesicles and microRNAs in microglia-glioma cross-talk.

Main Results:

  • Microglia exhibit a dual role: M1 phenotype is tumoricidal, while M2 phenotype promotes tumor growth and infiltration.
  • Microglia polarization is influenced by complex signaling pathways and cross-talk with glioma cells, with extracellular vesicles and miRNAs playing a key role.
  • The specific microglial phenotype correlates with patient prognosis, and its pathological assessment can predict outcomes.

Conclusions:

  • Understanding microglia polarization and their interaction with glioma cells is crucial for HGG management.
  • Engineered microglia and pharmacological modulation of microglia-glioma cross-talk represent promising avenues for novel HGG therapies.
  • Targeting the peritumoral microenvironment, particularly microglia, holds potential for improving surgical resection and therapeutic efficacy in HGGs.